These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7471466)

  • 1. Serial assessment of doxorubicin cardiotoxicity in pediatric patients with quantitative radionuclide angiocardiography.
    Moodie DS; Dyment PG; Napoli C; Cook SA
    Cleve Clin Q; 1980; 47(4):327-31. PubMed ID: 7471466
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance.
    Choi BW; Berger HJ; Schwartz PE; Alexander J; Wackers FJ; Gottschalk A; Zaret BL
    Am Heart J; 1983 Oct; 106(4 Pt 1):638-43. PubMed ID: 6613807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionuclide ejection fraction in doxorubicin cardiotoxicity.
    Morgan GW; McIlveen BM; Freedman A; Murray IP
    Cancer Treat Rep; 1981; 65(7-8):629-38. PubMed ID: 7248982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era.
    Mitani I; Jain D; Joska TM; Burtness B; Zaret BL
    J Nucl Cardiol; 2003; 10(2):132-9. PubMed ID: 12673177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity.
    McKillop JH; Bristow MR; Goris ML; Billingham ME; Bockemuehl K
    Am Heart J; 1983 Nov; 106(5 Pt 1):1048-56. PubMed ID: 6637763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of left ventricular effects of hydralazine in heart failure.
    Deglin SM; Jain AC; Harris WS
    Cardiology; 1980; 66(4):193-8. PubMed ID: 7448835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-123 MIBG and serial radionuclide angiocardiography in doxorubicin-related cardiotoxicity.
    Valdés Olmos RA; ten Bokkel Huinink WW; Greve JC; Hoefnagel CA
    Clin Nucl Med; 1992 Mar; 17(3):163-7. PubMed ID: 1611784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator therapy for congestive heart failure.
    Fouad FM
    Cardiovasc Clin; 1981; 12(2):127-35. PubMed ID: 7344769
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in left ventricular diastolic function with doxorubicin therapy.
    Lee BH; Goodenday LS; Muswick GJ; Yasnoff WA; Leighton RF; Skeel RT
    J Am Coll Cardiol; 1987 Jan; 9(1):184-8. PubMed ID: 3794095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionucleotide ejection fraction and prediction of doxorubicin cardiotoxicity.
    Morgan GW; Choy D; Freedman A
    Lancet; 1978 Jun; 1(8077):1315-6. PubMed ID: 78081
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion.
    Marshall RC; Berger HJ; Costin JC; Freedman GS; Wolberg J; Cohen LS; Gottschalk A; Zaret BL
    Circulation; 1977 Nov; 56(5):820-9. PubMed ID: 912845
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of amiodarone on ventricular function as measured by gated radionuclide angiography.
    Trobaugh GB; Kudenchuk PJ; Greene HL; Tutt RC; Kingston E; Gorham JR; Gross BW; Graham EL; Sears GK; Werner JA
    Am J Cardiol; 1984 Dec; 54(10):1263-6. PubMed ID: 6507296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil in chronic stable angina: amelioration of pacing-induced abnormalities of left ventricular ejection fraction, regional wall motion, lactate metabolism and hemodynamics.
    Hecht HS; Chew CY; Burnam MH; Hopkins J; Schnugg S; Singh BN
    Am J Cardiol; 1981 Sep; 48(3):536-44. PubMed ID: 6267926
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective right ventricular dysfunction following doxorubicin therapy.
    Sperber AD; Cantor AA; Biran H; Keynan A
    Isr J Med Sci; 1987 Aug; 23(8):896-9. PubMed ID: 3679793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide evaluation of doxorubicin cardiotoxicity: the need for cautious interpretation.
    Dey HM; Kassamali H
    Clin Nucl Med; 1988 Aug; 13(8):565-8. PubMed ID: 3168370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and use of vasodilators in the management of congestive heart failure.
    Lakier JB; Khaja F; Stein PD
    Am Heart J; 1979 Apr; 97(4):519-26. PubMed ID: 371379
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing adriamycin-induced early cardiotoxicity by estimating left ventricular ejection fraction using technetium-99m multiple-gated acquisition scan and echocardiography.
    Fatima N; Zaman MU; Hashmi A; Kamal S; Hameed A
    Nucl Med Commun; 2011 May; 32(5):381-5. PubMed ID: 21346663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study.
    Lahiri A; Robinson CW; Kohli RS; Caruana MP; Raftery EB
    Clin Cardiol; 1986 Jun; 9(6):257-61. PubMed ID: 3720049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.